Related Experiment Videos
Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits
1Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City 84112, USA.
Abstract:
Taxol and Taxotere propagate apoptosis in Jurkat T cells via molecular signals that coincide with the appearance of two distinct cell populations. Cell cycle arrest in G2-M phase and activation of cell cycle-dependent kinases begin within 2 h and extend to most cells by 16 h. Phosphorylation of Bcl-2 also begins within 2 h and intensifies from 2-16 h. Cell cycle arrest, activation of mitotic kinases, and phosphorylation of Bcl-2 coincided with the appearance of a population of metastable cells that accumulate YO-PRO-1 dye, are resistant to the caspase inhibitor carbobenzoxy-L-aspartyl-alpha-[(2,6-dichlorobenzoyl)oxy]methane, and have intact genomic DNA. Phosphorylation and deactivation of kinases that relay survival/mitogenesis signals in T cells begin after 8 h and are prominent by 12-16 h. Deactivated kinases include c-Raf-1, p44 extracellular receptor kinase, and the tyrosine kinases c-Lck and ZAP-70. Activation of Mr 40,000 and Mr 52,000 kinases is also prominent by 12-16 h. The modulation of all these kinases coincided with the activation of caspase-3 at 12 h and the appearance of a population of apoptotic cells that accumulate YO-PRO-1, are susceptible to the caspase inhibitor carbobenzoxy-L-aspartyl-alpha-[(2,6-dichloro-benzoyl)oxy]methane, and contain fragmented genomic DNA. This distinctive apoptosis signaling pathway may help account for the superior cytotoxic efficacy of taxanes in certain types of cancer.
Insights
Taxol and Taxotere induce apoptosis in T cells by arresting the cell cycle and altering kinase activity, leading to distinct cell populations. This pathway may explain taxanes' effectiveness against certain cancers.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Taxanes like Taxol and Taxotere are chemotherapy drugs.
- Apoptosis is programmed cell death, crucial in cancer treatment.
- Understanding taxane-induced apoptosis in T cells is key to improving cancer therapy.
Purpose of the Study:
- To elucidate the molecular signaling pathways of taxane-induced apoptosis in Jurkat T cells.
- To identify distinct cell populations and their characteristics during taxane treatment.
- To correlate kinase activity modulation with apoptosis progression.
Main Methods:
- Cell cycle analysis (G2-M phase arrest).
- Western blotting or kinase assays to assess phosphorylation and activity of Bcl-2 and various kinases (e.g., c-Raf-1, ERK, Lck, ZAP-70).
- Flow cytometry using YO-PRO-1 dye to identify apoptotic and metastable cells.
- Caspase activity assays.
Main Results:
- Taxanes induced G2-M cell cycle arrest and mitotic kinase activation within 2-16 hours.
- Bcl-2 phosphorylation increased, coinciding with a metastable cell population resistant to caspase inhibitors.
- Survival/mitogenesis signaling kinases (c-Raf-1, ERK, Lck, ZAP-70) were deactivated after 8 hours, preceding caspase-3 activation and the appearance of apoptotic cells.
- Distinct populations of metastable and apoptotic cells emerged, differing in YO-PRO-1 uptake, caspase inhibitor sensitivity, and DNA integrity.
Conclusions:
- Taxanes trigger a unique apoptosis signaling cascade in T cells involving cell cycle arrest, kinase modulation, and the formation of distinct metastable and apoptotic cell populations.
- The observed pathway provides insight into the cytotoxic mechanisms of taxanes.
- This understanding could contribute to developing more effective taxane-based cancer therapies.